Conferences - Results from #9460

ASCO 2013 - Poster: Inhibition of androgen receptor nuclear import by docetaxel, cabazitaxel, abiraterone and enzalutamide: a potential mechanism for cross-resistance in castration-resistant prostate cancer June 5, 2013

ASCO 2013 - Poster: Inhibition of androgen receptor nuclear import by docetaxel, cabazitaxel, abiraterone and enzalutamide: a potential mechanism for cross-resistance in castration-resistant prostate cancer June 5, 2013

ASCO 2013 - Podcast: Inhibition of androgen receptor nuclear import by docetaxel, cabazitaxel, abiraterone and enzalutamide: a potential mechanism for cross-resistance in castration-resistant prostate cancer June 5, 2013

ASCO 2013 - Podcast: Inhibition of androgen receptor nuclear import by docetaxel, cabazitaxel, abiraterone and enzalutamide: a potential mechanism for cross-resistance in castration-resistant prostate cancer June 5, 2013

ASCO 2013 - Poster: Impact of concomitant bone-targeted therapies on outcomes in metastatic castration-resistant prostate cancer patients without prior chemotherapy treated with abiraterone acetate or prednisone June 5, 2013

ASCO 2013 - Podcast: Impact of concomitant bone-targeted therapies on outcomes in metastatic castration-resistant prostate cancer patients without prior chemotherapy treated with abiraterone acetate or prednisone June 5, 2013

ASCO 2013 - Podcast: A discussion of the implementation and sequencing of treatment with sipuleucel-T for men with metastatic castration-resistant prostate cancer (mCRPC): Key messages from poster presentations at ASCO June 5, 2013

ASCO 2013 - Slide Presentation: Localized and hormone sensitive prostate cancer: Best practices June 4, 2013

ASCO 2013 - Slide Presentation: Localized and hormone sensitive prostate cancer: Best practices June 4, 2013

ASCO 2013 - Podcast: Localized and hormone sensitive prostate cancer: Best practices June 4, 2013

ASCO 2013 - Podcast: Localized and hormone sensitive prostate cancer: Best practices June 4, 2013

ASCO 2013 - Slide Presentation: Efficacy and safety of enzalutamide (ENZA) monotherapy in hormone-naive prostate cancer (HNPC) June 4, 2013

ASCO 2013 - Slide Presentation: Efficacy and safety of enzalutamide (ENZA) monotherapy in hormone-naive prostate cancer (HNPC) June 4, 2013

ASCO 2013 - Podcast: Efficacy and safety of enzalutamide (ENZA) monotherapy in hormone-naive prostate cancer (HNPC) June 4, 2013

ASCO 2013 - Slide Presentation: Prolaris: A novel genetic test for prostate cancer prognosis June 4, 2013

ASCO 2013 - Slide Presentation: Prolaris: A novel genetic test for prostate cancer prognosis June 4, 2013

ASCO 2013 - Podcast: Prolaris: A novel genetic test for prostate cancer prognosis June 4, 2013

ASCO 2013 - Podcast: Prolaris: A novel genetic test for prostate cancer prognosis June 4, 2013

ASCO 2013 - Poster: The genomic relationship among matched prostate cancer foci June 3, 2013

ASCO 2013 - Poster: The genomic relationship among matched prostate cancer foci June 3, 2013

Page 474 of 507